Deutsche Bank raised the firm’s price target on 10x Genomics (TXG) to $17 from $16 and keeps a Hold rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TXG:
- 10x Genomics price target raised to $19 from $18 at TD Cowen
- Neutral on 10x Genomics: Solid Competitive Position but Cautious Spending and Unclear Growth Keep Rating at Hold
- 10x Genomics price target raised to $20 from $15 at Stifel
- 10x Genomics price target raised to $22 from $20 at Canaccord
- Maintaining a Neutral Hold: Solid Q4 Beat but Limited 2026 Growth Visibility and Valuation Upside